Compare CMPS & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMPS | NXP |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 778.7M | 728.1M |
| IPO Year | 2020 | 1995 |
| Metric | CMPS | NXP |
|---|---|---|
| Price | $5.49 | $14.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $27.14 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 117.9K |
| Earning Date | 03-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.25 | $13.30 |
| 52 Week High | $8.90 | $14.65 |
| Indicator | CMPS | NXP |
|---|---|---|
| Relative Strength Index (RSI) | 36.12 | 44.72 |
| Support Level | $4.78 | $14.27 |
| Resistance Level | $7.02 | $14.59 |
| Average True Range (ATR) | 0.40 | 0.12 |
| MACD | -0.16 | -0.03 |
| Stochastic Oscillator | 21.37 | 33.33 |
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.